DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20203422

The comparison of effects of Roux-n-y gastric bypass and sleeve gastrectomy on excess weight loss in morbidly obese patients

Okan Murat Akturk, Baris Dogu Yildiz

Abstract


Background: Obesity an important health problem which has become a worldwide epidemic that effects both developed countries and developing countries. Bariatric surgery is the most efficient cure for morbid obesity. Authors retrospectively reviewed the results of different techniques in bariatric surgery to assess the efficiency of initial operations.

Methods: The medical files and operation notes and the one-year follow-up of patients were reviewed. The outcomes of sleeve gastrectomy (SG) and gastric roux-n-y bypass (RYGBP) operations were reviewed and their effects on excess weight loss were investigated.

Results: Overall, there were 97 patients included in the study, the majority of which were female (87/97, or 90%). The mean age of the SG group was 42.01±8.48 years versus 36±8.32 years in the RYGBP group, with p=0.007. Excess weight loss percentages were 51.7% and 57% for sleeve gastrectomy and RYGBP, respectively, p=0.491. Both operations are effective in reducing comorbidities.

Conclusions: In the RYGBP procedure there is more excess weight loss than the results of SG procedure but the difference is not statistically significant. In both procedures, the initial results on weight loss and reduction of comorbidities are comparable. Because SG is less traumatic and relatively easier to perform, it can be the preferred operation for morbid obesity.


Keywords


Excess weight loss, Morbid obesity, Roux and Y Gastrik bypass, Sleeve gastrectomy

Full Text:

PDF

References


Obesity and overweight. Available at: https://www.who.int/news-room/fact-sheets/detail/ obesity-and-overweight. Accessed on 30th November 2019.

Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care. 2002;25:1551-6.

Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28:169-80.

Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33:673-89.

National heart, lung, and blood institute (NHLBI) and national institute for diabetes and digestive and kidney diseases (NIDDKD). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Obes Res. 1998;6(suppl 2):51S-210S.

Busetto L. Timing of bariatric surgery in people with obesity and diabetes. Ann Transl Med. 2015;3:94.

Arterburn DE, Courcoulas AP. Bariatric surgery for obesity and metabolic conditions in adults. BMJ. 2014;27;349:g3961.

Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-56.e5.

Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, et al. Roux-en-Y gastric bypass for diabetes (the diabetes surgery study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3:413-22.

Abdeen G, le Roux CW. Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Review Obes Surg. 2016;26:410-21.

Kehagias I, Zygomalas A, Karavias D, Karamanakos S. Sleeve gastrectomy: have we finally found the holy grail of bariatric surgery? A review of the literature. Eur Rev Med Pharmacol Sci. 2016;20:4930-42.

Purnell JQ. Definitions, classification, and epidemiology of obesity. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000. Available at: https://www.ncbi.nlm.nih.gov/books /NBK279167/. Accessed on 30th November 2019.

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md: National Heart, Lung, and Blood Institute; 1998.

Insurance ML. Metropolitan height and weight tables. Stat Bull Metrop Life Insur Co. 1983;64:2-9.

Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133-5.

Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol. 2008;14:821-7.

Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401-7.

Peterli R, Borbély Y, Kern B, Gass M, Peters T, Thurnheer M, et al. Early results of the Swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258:690-4.

Lim DM, Taller J, Bertucci W, Riffenburgh RH, O’Leary J, Wisbach G. Comparison of laparoscopic sleeve gastrectomy to laparoscopic Roux-en-Y gastric bypass for morbid obesity in a military institution. Surg Obes Relat Dis. 2014;10:269-76.

Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial. Surg Obes Relat Dis. 2011;7:561-8.

Tavakkoli A, Robert N. Cooney. Metabolic changes following bariatric surgery. Current Surgical Therapy: Expert Consult - Online Current Therapy, 2013.

Baskota A, Li S, Dhakal N, Liu G, Tian H. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS One. 2015;13;10(7):e0132335.

Peterli R, Wölnerhanssen BK, Vetter D, Nett P, Gass M, Borbély Y, et al. Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for morbid bbesity-3-year outcomes of the prospective randomized Swiss multicenter bypass or sleeve study (SM-BOSS). Ann Surg. 2017;265:466-73.

Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg. 2011;21:1650-6.

Zhang N, Maffei A, Cerabona T, Pahuja A, Omana J, Kaul A. Reduction in obesity-related comorbidities: is gastric bypass better than sleeve gastrectomy? Surg Endosc. 2013;27:1273-80.

Lee WJ, Chong K, Ser KH, Lee YC, Chen SC, Chen JC, Tsai MH, Chuang LM. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143-8.

Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22:740-8.

Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252:319-24.

Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, Gfrerer L, Ludvik B, Zacherl, Prager G. Sleeve gastrectomy as sole and definitive bariatric procedure:5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535-40.

D'Hondt M, Vanneste S, Pottel H, Devriendt D, Van Rooy F, Vansteenkiste F. Laparoscopic sleeve gastrectomy as a single-stage procedure for the treatment of morbid obesity and the resulting quality of life, resolution of co-morbidities, food tolerance, and 6-year weight loss. Surg Endosc. 2011;25:2498-504.

Sarela AI, Dexter SP, O'Kane M, Menon A, McMahon MJ. Long-term follow-up after laparoscopic sleeve-gastrectomy: 8-9-year results. Surg Obes Relat Dis. 2012;8:679-84.